

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of B cell receptor signaling pathway (GO:0050855) | 6.78201454 |
| 2 | negative regulation of cell killing (GO:0031342) | 6.15878807 |
| 3 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.15878807 |
| 4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.14743372 |
| 5 | negative T cell selection (GO:0043383) | 5.06238037 |
| 6 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.04543373 |
| 7 | negative regulation of T cell mediated immunity (GO:0002710) | 5.00289557 |
| 8 | negative thymic T cell selection (GO:0045060) | 4.98561597 |
| 9 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.94037713 |
| 10 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.71855850 |
| 11 | regulation of gamma-delta T cell activation (GO:0046643) | 4.65545357 |
| 12 | positive regulation of granulocyte differentiation (GO:0030854) | 4.53949799 |
| 13 | cellular response to interleukin-15 (GO:0071350) | 4.36438315 |
| 14 | response to interleukin-15 (GO:0070672) | 4.31325383 |
| 15 | positive T cell selection (GO:0043368) | 4.29738123 |
| 16 | hepatocyte apoptotic process (GO:0097284) | 4.25786107 |
| 17 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.21453234 |
| 18 | positive thymic T cell selection (GO:0045059) | 4.16235866 |
| 19 | T cell migration (GO:0072678) | 3.94694279 |
| 20 | microglial cell activation (GO:0001774) | 3.90439311 |
| 21 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.89553883 |
| 22 | regulation of memory T cell differentiation (GO:0043380) | 3.83926335 |
| 23 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.83257791 |
| 24 | B cell receptor signaling pathway (GO:0050853) | 3.79728798 |
| 25 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.74204360 |
| 26 | detection of molecule of bacterial origin (GO:0032490) | 3.70978337 |
| 27 | neutrophil mediated immunity (GO:0002446) | 3.64418517 |
| 28 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.58929363 |
| 29 | cellular extravasation (GO:0045123) | 3.53565527 |
| 30 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.53186923 |
| 31 | interferon-gamma production (GO:0032609) | 3.52689624 |
| 32 | regulation of regulatory T cell differentiation (GO:0045589) | 3.50312613 |
| 33 | negative regulation of adaptive immune response (GO:0002820) | 3.46488558 |
| 34 | negative regulation of interleukin-12 production (GO:0032695) | 3.45388672 |
| 35 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.44230975 |
| 36 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.44230975 |
| 37 | modulation by symbiont of host immune response (GO:0052553) | 3.44230975 |
| 38 | positive regulation by symbiont of host defense response (GO:0052509) | 3.44230975 |
| 39 | modulation by symbiont of host defense response (GO:0052031) | 3.44230975 |
| 40 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.44230975 |
| 41 | activated T cell proliferation (GO:0050798) | 3.43616283 |
| 42 | myeloid leukocyte mediated immunity (GO:0002444) | 3.40431266 |
| 43 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 3.38116658 |
| 44 | negative regulation of B cell proliferation (GO:0030889) | 3.36205337 |
| 45 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.33591665 |
| 46 | T cell selection (GO:0045058) | 3.32559533 |
| 47 | regulation of B cell differentiation (GO:0045577) | 3.31707441 |
| 48 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.26260736 |
| 49 | thymic T cell selection (GO:0045061) | 3.24561693 |
| 50 | histone mRNA catabolic process (GO:0071044) | 3.22137169 |
| 51 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.19009466 |
| 52 | neutrophil activation (GO:0042119) | 3.14828038 |
| 53 | positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110 | 3.12942701 |
| 54 | mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686) | 3.12942701 |
| 55 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.10135794 |
| 56 | mast cell activation (GO:0045576) | 3.09699605 |
| 57 | regulation of granulocyte differentiation (GO:0030852) | 3.07526377 |
| 58 | positive regulation of B cell differentiation (GO:0045579) | 3.07467680 |
| 59 | response to host immune response (GO:0052572) | 3.05907684 |
| 60 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.05907684 |
| 61 | negative regulation of NF-kappaB import into nucleus (GO:0042347) | 3.04776072 |
| 62 | natural killer cell activation involved in immune response (GO:0002323) | 3.04529269 |
| 63 | leukocyte aggregation (GO:0070486) | 3.04486676 |
| 64 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.03907153 |
| 65 | regulation of MHC class I biosynthetic process (GO:0045343) | 3.03484381 |
| 66 | dosage compensation (GO:0007549) | 2.99209210 |
| 67 | B cell proliferation (GO:0042100) | 2.98556365 |
| 68 | alpha-beta T cell differentiation (GO:0046632) | 2.96338859 |
| 69 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.95606239 |
| 70 | tolerance induction (GO:0002507) | 2.95578052 |
| 71 | mast cell degranulation (GO:0043303) | 2.95393916 |
| 72 | mast cell activation involved in immune response (GO:0002279) | 2.95393916 |
| 73 | macrophage activation (GO:0042116) | 2.95258789 |
| 74 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.94426053 |
| 75 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.94039693 |
| 76 | negative regulation of B cell mediated immunity (GO:0002713) | 2.92605948 |
| 77 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 2.92605948 |
| 78 | necroptotic process (GO:0070266) | 2.91735947 |
| 79 | detection of external biotic stimulus (GO:0098581) | 2.91446162 |
| 80 | macrophage activation involved in immune response (GO:0002281) | 2.90780229 |
| 81 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.88633678 |
| 82 | myeloid cell activation involved in immune response (GO:0002275) | 2.87929633 |
| 83 | neutrophil activation involved in immune response (GO:0002283) | 2.87501744 |
| 84 | establishment of protein localization to Golgi (GO:0072600) | 2.87067894 |
| 85 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.86481096 |
| 86 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.85883427 |
| 87 | necrotic cell death (GO:0070265) | 2.85705591 |
| 88 | leukocyte degranulation (GO:0043299) | 2.85311367 |
| 89 | programmed necrotic cell death (GO:0097300) | 2.83598943 |
| 90 | protein targeting to Golgi (GO:0000042) | 2.83499520 |
| 91 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.82278681 |
| 92 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.81651985 |
| 93 | alpha-beta T cell activation (GO:0046631) | 2.80885433 |
| 94 | lymph node development (GO:0048535) | 2.80685763 |
| 95 | negative regulation of protein oligomerization (GO:0032460) | 2.80422897 |
| 96 | regulation of cell killing (GO:0031341) | 2.79390978 |
| 97 | histone H3-K36 demethylation (GO:0070544) | 2.79286551 |
| 98 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.77783732 |
| 99 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.76517319 |
| 100 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.75684505 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.72736489 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.44391935 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.19057491 |
| 4 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.55349029 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.46966223 |
| 6 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.25031225 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.98632947 |
| 8 | MYB_26560356_Chip-Seq_TH2_Human | 2.96059381 |
| 9 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.90701187 |
| 10 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.75935230 |
| 11 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.71318154 |
| 12 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.53388875 |
| 13 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.50077687 |
| 14 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.40137583 |
| 15 | MYB_26560356_Chip-Seq_TH1_Human | 2.39685128 |
| 16 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.37965189 |
| 17 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.28483899 |
| 18 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.26661017 |
| 19 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.18851903 |
| 20 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.06374544 |
| 21 | GATA3_26560356_Chip-Seq_TH2_Human | 2.05866496 |
| 22 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.01757165 |
| 23 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.01226476 |
| 24 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.92059819 |
| 25 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.80526039 |
| 26 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.74813018 |
| 27 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.71546093 |
| 28 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.70923769 |
| 29 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.69533895 |
| 30 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.66992817 |
| 31 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.64988248 |
| 32 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.59617974 |
| 33 | SPI1_23127762_ChIP-Seq_K562_Human | 1.59531557 |
| 34 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.58028727 |
| 35 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.55689560 |
| 36 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.53583751 |
| 37 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.52896761 |
| 38 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.52522083 |
| 39 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.47858145 |
| 40 | MAF_26560356_Chip-Seq_TH1_Human | 1.46930459 |
| 41 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.46598687 |
| 42 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.46161942 |
| 43 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45167194 |
| 44 | UTX_26944678_Chip-Seq_JUKART_Human | 1.42655391 |
| 45 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.41961283 |
| 46 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.41106986 |
| 47 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.37923756 |
| 48 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.35860822 |
| 49 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.35409585 |
| 50 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.34355467 |
| 51 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.33304368 |
| 52 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.32290779 |
| 53 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.31070185 |
| 54 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29491668 |
| 55 | GATA1_22025678_ChIP-Seq_K562_Human | 1.25565609 |
| 56 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.24032850 |
| 57 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.19326259 |
| 58 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.19187236 |
| 59 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.19186900 |
| 60 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.17783387 |
| 61 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.14722623 |
| 62 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.14157212 |
| 63 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.13008885 |
| 64 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.11560479 |
| 65 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.09866784 |
| 66 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.07973524 |
| 67 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.06309508 |
| 68 | MAF_26560356_Chip-Seq_TH2_Human | 1.04976767 |
| 69 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.04939291 |
| 70 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.04659561 |
| 71 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.04318355 |
| 72 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.03505405 |
| 73 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.03382621 |
| 74 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.99008329 |
| 75 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.98123395 |
| 76 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.95975066 |
| 77 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.94517013 |
| 78 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93544293 |
| 79 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.93480789 |
| 80 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.91935603 |
| 81 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.91912530 |
| 82 | GATA2_19941826_ChIP-Seq_K562_Human | 0.91087198 |
| 83 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.90995803 |
| 84 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.90876681 |
| 85 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.90516251 |
| 86 | GATA3_26560356_Chip-Seq_TH1_Human | 0.90245015 |
| 87 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.89752888 |
| 88 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.88794762 |
| 89 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.88589109 |
| 90 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.87422212 |
| 91 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.87205869 |
| 92 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.87205869 |
| 93 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.86789201 |
| 94 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.86506663 |
| 95 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.86291736 |
| 96 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.85053012 |
| 97 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.84775170 |
| 98 | GATA1_19941826_ChIP-Seq_K562_Human | 0.84559296 |
| 99 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.83668599 |
| 100 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.82511494 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 4.78368978 |
| 2 | MP0000569_abnormal_digit_pigmentation | 4.41918283 |
| 3 | MP0001835_abnormal_antigen_presentation | 3.46012783 |
| 4 | MP0005671_abnormal_response_to | 3.33200921 |
| 5 | MP0003763_abnormal_thymus_physiology | 3.16721642 |
| 6 | MP0008260_abnormal_autophagy | 3.10899766 |
| 7 | MP0001800_abnormal_humoral_immune | 3.06904217 |
| 8 | MP0003436_decreased_susceptibility_to | 2.80876439 |
| 9 | MP0003787_abnormal_imprinting | 2.74438899 |
| 10 | MP0005000_abnormal_immune_tolerance | 2.64238508 |
| 11 | MP0004381_abnormal_hair_follicle | 2.61806162 |
| 12 | MP0002723_abnormal_immune_serum | 2.47172987 |
| 13 | MP0001819_abnormal_immune_cell | 2.44780879 |
| 14 | MP0002420_abnormal_adaptive_immunity | 2.44243617 |
| 15 | MP0002452_abnormal_antigen_presenting | 2.41648466 |
| 16 | MP0002419_abnormal_innate_immunity | 2.39214540 |
| 17 | MP0000685_abnormal_immune_system | 2.24198456 |
| 18 | MP0003303_peritoneal_inflammation | 2.21536585 |
| 19 | MP0005025_abnormal_response_to | 2.18355971 |
| 20 | MP0003656_abnormal_erythrocyte_physiolo | 2.14336620 |
| 21 | MP0005075_abnormal_melanosome_morpholog | 2.08234512 |
| 22 | MP0002166_altered_tumor_susceptibility | 2.07712053 |
| 23 | MP0002398_abnormal_bone_marrow | 2.04336655 |
| 24 | MP0009785_altered_susceptibility_to | 1.98538393 |
| 25 | MP0000716_abnormal_immune_system | 1.91795020 |
| 26 | MP0005387_immune_system_phenotype | 1.90954908 |
| 27 | MP0001790_abnormal_immune_system | 1.90954908 |
| 28 | MP0005174_abnormal_tail_pigmentation | 1.89551764 |
| 29 | MP0008877_abnormal_DNA_methylation | 1.83835607 |
| 30 | MP0003828_pulmonary_edema | 1.82432561 |
| 31 | MP0003866_abnormal_defecation | 1.74557725 |
| 32 | MP0005464_abnormal_platelet_physiology | 1.71490765 |
| 33 | MP0000689_abnormal_spleen_morphology | 1.71054956 |
| 34 | MP0006082_CNS_inflammation | 1.70984797 |
| 35 | MP0000703_abnormal_thymus_morphology | 1.69182923 |
| 36 | MP0002722_abnormal_immune_system | 1.66525249 |
| 37 | MP0002148_abnormal_hypersensitivity_rea | 1.66424245 |
| 38 | MP0002405_respiratory_system_inflammati | 1.66189966 |
| 39 | MP0005310_abnormal_salivary_gland | 1.58377468 |
| 40 | MP0000015_abnormal_ear_pigmentation | 1.57614016 |
| 41 | MP0004947_skin_inflammation | 1.56379993 |
| 42 | MP0003172_abnormal_lysosome_physiology | 1.54530580 |
| 43 | MP0002138_abnormal_hepatobiliary_system | 1.53269555 |
| 44 | MP0003300_gastrointestinal_ulcer | 1.51990103 |
| 45 | MP0002429_abnormal_blood_cell | 1.51614537 |
| 46 | MP0001533_abnormal_skeleton_physiology | 1.49968063 |
| 47 | MP0001845_abnormal_inflammatory_respons | 1.49204545 |
| 48 | MP0002396_abnormal_hematopoietic_system | 1.47649735 |
| 49 | MP0004883_abnormal_blood_vessel | 1.44328710 |
| 50 | MP0002006_tumorigenesis | 1.37864016 |
| 51 | MP0001851_eye_inflammation | 1.37432924 |
| 52 | MP0000465_gastrointestinal_hemorrhage | 1.31075147 |
| 53 | MP0009764_decreased_sensitivity_to | 1.24948707 |
| 54 | MP0001986_abnormal_taste_sensitivity | 1.18285393 |
| 55 | MP0001853_heart_inflammation | 1.15475242 |
| 56 | MP0010155_abnormal_intestine_physiology | 1.13619130 |
| 57 | MP0002332_abnormal_exercise_endurance | 1.13120671 |
| 58 | MP0004484_altered_response_of | 1.11548373 |
| 59 | MP0005167_abnormal_blood-brain_barrier | 1.05493796 |
| 60 | MP0008469_abnormal_protein_level | 1.00186423 |
| 61 | MP0009333_abnormal_splenocyte_physiolog | 0.99110513 |
| 62 | MP0002876_abnormal_thyroid_physiology | 0.97957933 |
| 63 | MP0005164_abnormal_response_to | 0.97954387 |
| 64 | MP0001545_abnormal_hematopoietic_system | 0.93657665 |
| 65 | MP0005397_hematopoietic_system_phenotyp | 0.93657665 |
| 66 | MP0002009_preneoplasia | 0.92815307 |
| 67 | MP0003690_abnormal_glial_cell | 0.91288929 |
| 68 | MP0002928_abnormal_bile_duct | 0.87825136 |
| 69 | MP0004264_abnormal_extraembryonic_tissu | 0.87193959 |
| 70 | MP0002998_abnormal_bone_remodeling | 0.86486998 |
| 71 | MP0006054_spinal_hemorrhage | 0.84043920 |
| 72 | MP0000858_altered_metastatic_potential | 0.83520081 |
| 73 | MP0000371_diluted_coat_color | 0.83376010 |
| 74 | MP0009763_increased_sensitivity_to | 0.77322136 |
| 75 | MP0004808_abnormal_hematopoietic_stem | 0.76481478 |
| 76 | MP0000427_abnormal_hair_cycle | 0.76022997 |
| 77 | MP0009278_abnormal_bone_marrow | 0.75846288 |
| 78 | MP0000604_amyloidosis | 0.74921811 |
| 79 | MP0005451_abnormal_body_composition | 0.74331663 |
| 80 | MP0004147_increased_porphyrin_level | 0.74217026 |
| 81 | MP0000249_abnormal_blood_vessel | 0.73941258 |
| 82 | MP0002277_abnormal_respiratory_mucosa | 0.73309210 |
| 83 | MP0003646_muscle_fatigue | 0.73252989 |
| 84 | MP0003195_calcinosis | 0.72899495 |
| 85 | MP0008057_abnormal_DNA_replication | 0.71094417 |
| 86 | MP0009765_abnormal_xenobiotic_induced | 0.68120677 |
| 87 | MP0003221_abnormal_cardiomyocyte_apopto | 0.67249676 |
| 88 | MP0002019_abnormal_tumor_incidence | 0.67210974 |
| 89 | MP0004130_abnormal_muscle_cell | 0.66241775 |
| 90 | MP0003183_abnormal_peptide_metabolism | 0.65401882 |
| 91 | MP0005376_homeostasis/metabolism_phenot | 0.64159290 |
| 92 | MP0003121_genomic_imprinting | 0.63754761 |
| 93 | MP0002136_abnormal_kidney_physiology | 0.63283248 |
| 94 | MP0005266_abnormal_metabolism | 0.62427076 |
| 95 | MP0002095_abnormal_skin_pigmentation | 0.61365675 |
| 96 | MP0002933_joint_inflammation | 0.59949857 |
| 97 | MP0002127_abnormal_cardiovascular_syste | 0.57889334 |
| 98 | MP0003091_abnormal_cell_migration | 0.52292094 |
| 99 | MP0005408_hypopigmentation | 0.51805938 |
| 100 | MP0002132_abnormal_respiratory_system | 0.49823588 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T lymphocytopenia (HP:0005403) | 5.88137365 |
| 2 | Abnormality of T cell number (HP:0011839) | 5.62456617 |
| 3 | Retrobulbar optic neuritis (HP:0100654) | 5.26218352 |
| 4 | Optic neuritis (HP:0100653) | 5.26218352 |
| 5 | Prostate neoplasm (HP:0100787) | 5.03899525 |
| 6 | Recurrent bacterial skin infections (HP:0005406) | 5.02577032 |
| 7 | Stomach cancer (HP:0012126) | 4.94901457 |
| 8 | Myositis (HP:0100614) | 4.78316633 |
| 9 | Orchitis (HP:0100796) | 4.69519322 |
| 10 | Stomatitis (HP:0010280) | 4.51674933 |
| 11 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.36427375 |
| 12 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 4.34485142 |
| 13 | Recurrent abscess formation (HP:0002722) | 4.29262963 |
| 14 | Abnormality of T cells (HP:0002843) | 4.15083765 |
| 15 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.12969244 |
| 16 | Recurrent fungal infections (HP:0002841) | 4.01828334 |
| 17 | Abnormality of the prostate (HP:0008775) | 3.93427398 |
| 18 | Gastrointestinal infarctions (HP:0005244) | 3.66950067 |
| 19 | IgG deficiency (HP:0004315) | 3.64230869 |
| 20 | Keratoconjunctivitis sicca (HP:0001097) | 3.62268122 |
| 21 | Eczematoid dermatitis (HP:0000976) | 3.60621242 |
| 22 | Recurrent cutaneous fungal infections (HP:0011370) | 3.49778491 |
| 23 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.49778491 |
| 24 | Recurrent skin infections (HP:0001581) | 3.44718172 |
| 25 | Keratoconjunctivitis (HP:0001096) | 3.43932309 |
| 26 | Leukocytosis (HP:0001974) | 3.29200035 |
| 27 | Vasculitis (HP:0002633) | 3.25675362 |
| 28 | Encephalitis (HP:0002383) | 3.25381231 |
| 29 | Thyroiditis (HP:0100646) | 3.25254696 |
| 30 | Abnormality of eosinophils (HP:0001879) | 3.16006787 |
| 31 | Autoimmune thrombocytopenia (HP:0001973) | 3.12604511 |
| 32 | IgM deficiency (HP:0002850) | 3.11277288 |
| 33 | Abnormality of T cell physiology (HP:0011840) | 3.08022964 |
| 34 | Meningitis (HP:0001287) | 3.05784496 |
| 35 | Panhypogammaglobulinemia (HP:0003139) | 3.04355731 |
| 36 | Recurrent viral infections (HP:0004429) | 3.01983782 |
| 37 | Arterial thrombosis (HP:0004420) | 2.97815858 |
| 38 | Severe combined immunodeficiency (HP:0004430) | 2.95412967 |
| 39 | Eosinophilia (HP:0001880) | 2.91829366 |
| 40 | Hemoptysis (HP:0002105) | 2.90428781 |
| 41 | Autoimmune hemolytic anemia (HP:0001890) | 2.87722619 |
| 42 | Pulmonary infiltrates (HP:0002113) | 2.81773012 |
| 43 | Spontaneous hematomas (HP:0007420) | 2.74020115 |
| 44 | Granulocytopenia (HP:0001913) | 2.72837055 |
| 45 | Mediastinal lymphadenopathy (HP:0100721) | 2.72176755 |
| 46 | Gingival bleeding (HP:0000225) | 2.66023790 |
| 47 | Inflammation of the large intestine (HP:0002037) | 2.65497309 |
| 48 | Pustule (HP:0200039) | 2.64633667 |
| 49 | Abnormality of male internal genitalia (HP:0000022) | 2.63642746 |
| 50 | Pulmonary embolism (HP:0002204) | 2.62384345 |
| 51 | Chest pain (HP:0100749) | 2.55077211 |
| 52 | Recurrent bronchitis (HP:0002837) | 2.50695597 |
| 53 | Slow saccadic eye movements (HP:0000514) | 2.50374687 |
| 54 | Gingivitis (HP:0000230) | 2.50153458 |
| 55 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.45477499 |
| 56 | Peritonitis (HP:0002586) | 2.44580065 |
| 57 | Gastrointestinal inflammation (HP:0004386) | 2.41305578 |
| 58 | Gangrene (HP:0100758) | 2.41219006 |
| 59 | IgA deficiency (HP:0002720) | 2.40113332 |
| 60 | Colitis (HP:0002583) | 2.39777537 |
| 61 | Acute hepatic failure (HP:0006554) | 2.34547058 |
| 62 | Periodontitis (HP:0000704) | 2.29854048 |
| 63 | Postural instability (HP:0002172) | 2.29530692 |
| 64 | Epistaxis (HP:0000421) | 2.18266459 |
| 65 | Urticaria (HP:0001025) | 2.15432547 |
| 66 | Abnormality of the columella (HP:0009929) | 2.15291465 |
| 67 | Amyotrophic lateral sclerosis (HP:0007354) | 2.15257980 |
| 68 | Anorexia (HP:0002039) | 2.14141860 |
| 69 | Prolonged bleeding time (HP:0003010) | 2.13367931 |
| 70 | Viral hepatitis (HP:0006562) | 2.09274842 |
| 71 | Combined immunodeficiency (HP:0005387) | 2.08712481 |
| 72 | Abnormality of B cell number (HP:0010975) | 2.07072307 |
| 73 | Agammaglobulinemia (HP:0004432) | 2.06424761 |
| 74 | Increased IgM level (HP:0003496) | 2.05878526 |
| 75 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.05851713 |
| 76 | Verrucae (HP:0200043) | 2.01825560 |
| 77 | Papilloma (HP:0012740) | 2.01825560 |
| 78 | Obstructive lung disease (HP:0006536) | 2.00911778 |
| 79 | Chronic obstructive pulmonary disease (HP:0006510) | 2.00911778 |
| 80 | Hypoplasia of the thymus (HP:0000778) | 1.99651658 |
| 81 | Glomerulopathy (HP:0100820) | 1.98671979 |
| 82 | Genetic anticipation (HP:0003743) | 1.97056459 |
| 83 | Abnormality of the pleura (HP:0002103) | 1.96905646 |
| 84 | Lymphopenia (HP:0001888) | 1.95108582 |
| 85 | Abnormality of macrophages (HP:0004311) | 1.95097118 |
| 86 | Alveolar cell carcinoma (HP:0006519) | 1.92515421 |
| 87 | Abnormality of the fingertips (HP:0001211) | 1.91249270 |
| 88 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.90351462 |
| 89 | Hematochezia (HP:0002573) | 1.90310477 |
| 90 | Metaphyseal dysplasia (HP:0100255) | 1.90106839 |
| 91 | Aplastic anemia (HP:0001915) | 1.85280057 |
| 92 | Neurodegeneration (HP:0002180) | 1.84058361 |
| 93 | Albinism (HP:0001022) | 1.83966403 |
| 94 | Ocular albinism (HP:0001107) | 1.83787076 |
| 95 | Facial diplegia (HP:0001349) | 1.83386510 |
| 96 | Conjunctival telangiectasia (HP:0000524) | 1.80825902 |
| 97 | Subacute progressive viral hepatitis (HP:0006572) | 1.79411573 |
| 98 | Fatigue (HP:0012378) | 1.76810192 |
| 99 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.74309003 |
| 100 | Pulmonary fibrosis (HP:0002206) | 1.73737016 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TAOK3 | 3.93581723 |
| 2 | RIPK4 | 3.51490855 |
| 3 | TXK | 3.38083238 |
| 4 | FES | 2.94861174 |
| 5 | GRK6 | 2.82113789 |
| 6 | MAP4K1 | 2.69332587 |
| 7 | IKBKE | 2.64857970 |
| 8 | BLK | 2.50594859 |
| 9 | JAK3 | 2.36407296 |
| 10 | SYK | 2.32136685 |
| 11 | MAP3K14 | 2.31413396 |
| 12 | FRK | 2.29353816 |
| 13 | CSK | 2.02119125 |
| 14 | BTK | 2.01394410 |
| 15 | PIK3CG | 1.85448231 |
| 16 | ITK | 1.81660976 |
| 17 | JAK1 | 1.79468387 |
| 18 | IRAK4 | 1.78281181 |
| 19 | MAP2K2 | 1.77747403 |
| 20 | PTK2B | 1.77106090 |
| 21 | TEC | 1.69502007 |
| 22 | BMPR2 | 1.65373577 |
| 23 | TYK2 | 1.44138318 |
| 24 | WNK1 | 1.42853006 |
| 25 | FGR | 1.42381548 |
| 26 | LYN | 1.38940486 |
| 27 | HCK | 1.36324652 |
| 28 | TNK2 | 1.34507855 |
| 29 | SGK2 | 1.33059953 |
| 30 | LCK | 1.31868606 |
| 31 | IKBKB | 1.31012791 |
| 32 | TRPM7 | 1.30091152 |
| 33 | TLK1 | 1.29876905 |
| 34 | MAP2K3 | 1.26512167 |
| 35 | CDK12 | 1.26183912 |
| 36 | STK4 | 1.23150710 |
| 37 | MARK3 | 1.20344103 |
| 38 | PIK3CA | 1.12503472 |
| 39 | PIM1 | 1.11548065 |
| 40 | IRAK1 | 1.11449097 |
| 41 | ZAP70 | 1.09957022 |
| 42 | FGFR3 | 1.07627963 |
| 43 | TBK1 | 1.02626565 |
| 44 | DYRK3 | 1.02391117 |
| 45 | JAK2 | 1.00276808 |
| 46 | GRK5 | 0.99262056 |
| 47 | KIT | 0.90158555 |
| 48 | ERBB2 | 0.89600888 |
| 49 | SRPK1 | 0.87945780 |
| 50 | CSF1R | 0.85544841 |
| 51 | PLK2 | 0.84950857 |
| 52 | CHUK | 0.83265820 |
| 53 | SGK3 | 0.79789876 |
| 54 | MAP3K2 | 0.76333864 |
| 55 | MAP3K13 | 0.75719160 |
| 56 | IRAK2 | 0.74006491 |
| 57 | DYRK1A | 0.73851847 |
| 58 | NLK | 0.73656741 |
| 59 | SGK494 | 0.71945498 |
| 60 | SGK223 | 0.71945498 |
| 61 | BRD4 | 0.71813044 |
| 62 | YES1 | 0.69254199 |
| 63 | EGFR | 0.67710278 |
| 64 | PRKCQ | 0.64897141 |
| 65 | MARK2 | 0.63611442 |
| 66 | STK10 | 0.63172760 |
| 67 | MAP3K6 | 0.61873593 |
| 68 | PDK1 | 0.58941312 |
| 69 | MAPK7 | 0.57239219 |
| 70 | NUAK1 | 0.55979038 |
| 71 | PRKAA2 | 0.55607407 |
| 72 | LRRK2 | 0.53900971 |
| 73 | STK38 | 0.53426947 |
| 74 | MATK | 0.52320702 |
| 75 | MAP4K2 | 0.51802541 |
| 76 | HIPK2 | 0.49817447 |
| 77 | TESK2 | 0.49808022 |
| 78 | SGK1 | 0.49203845 |
| 79 | CAMKK2 | 0.48731055 |
| 80 | RPS6KA4 | 0.47305586 |
| 81 | EPHA3 | 0.47128307 |
| 82 | PAK3 | 0.46560933 |
| 83 | ZAK | 0.45475908 |
| 84 | NEK6 | 0.44797757 |
| 85 | CDC42BPA | 0.44130859 |
| 86 | ADRBK1 | 0.43288414 |
| 87 | CAMK4 | 0.41310886 |
| 88 | ERBB3 | 0.40704005 |
| 89 | SIK2 | 0.40062902 |
| 90 | FYN | 0.39769622 |
| 91 | ABL1 | 0.39610988 |
| 92 | IGF1R | 0.39087408 |
| 93 | SIK3 | 0.39031180 |
| 94 | ACVR1B | 0.38177168 |
| 95 | MAP3K5 | 0.36184754 |
| 96 | RPS6KA5 | 0.35335175 |
| 97 | MAPK11 | 0.34332340 |
| 98 | STK11 | 0.33884799 |
| 99 | MAPKAPK2 | 0.33362225 |
| 100 | MAP3K1 | 0.32933924 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.47738559 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 3.04333323 |
| 3 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.58335548 |
| 4 | Allograft rejection_Homo sapiens_hsa05330 | 2.51088980 |
| 5 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.44834730 |
| 6 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.43468798 |
| 7 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.34114581 |
| 8 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.28851383 |
| 9 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.28208309 |
| 10 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.22010686 |
| 11 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.17785664 |
| 12 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.15402549 |
| 13 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.14009828 |
| 14 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.13120159 |
| 15 | Asthma_Homo sapiens_hsa05310 | 2.04921893 |
| 16 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.98286000 |
| 17 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.86012205 |
| 18 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.80884999 |
| 19 | Measles_Homo sapiens_hsa05162 | 1.70659455 |
| 20 | Tuberculosis_Homo sapiens_hsa05152 | 1.67202946 |
| 21 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.58022540 |
| 22 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.54881040 |
| 23 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.51926023 |
| 24 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.51273703 |
| 25 | Platelet activation_Homo sapiens_hsa04611 | 1.50493263 |
| 26 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.48901308 |
| 27 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.46812872 |
| 28 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.45020100 |
| 29 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.40259981 |
| 30 | Malaria_Homo sapiens_hsa05144 | 1.39227559 |
| 31 | Influenza A_Homo sapiens_hsa05164 | 1.35302233 |
| 32 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.33783705 |
| 33 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.30116350 |
| 34 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.28053619 |
| 35 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.26691699 |
| 36 | Hepatitis B_Homo sapiens_hsa05161 | 1.19551479 |
| 37 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.19531074 |
| 38 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.17926483 |
| 39 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.16529086 |
| 40 | Legionellosis_Homo sapiens_hsa05134 | 1.14744775 |
| 41 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.10175731 |
| 42 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.04905994 |
| 43 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.02323609 |
| 44 | Circadian rhythm_Homo sapiens_hsa04710 | 1.01014796 |
| 45 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.98404481 |
| 46 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.94779461 |
| 47 | Viral myocarditis_Homo sapiens_hsa05416 | 0.93247294 |
| 48 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.93240013 |
| 49 | Apoptosis_Homo sapiens_hsa04210 | 0.92143764 |
| 50 | Hepatitis C_Homo sapiens_hsa05160 | 0.84082785 |
| 51 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.83532129 |
| 52 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.82139503 |
| 53 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.77704855 |
| 54 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.74009102 |
| 55 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.72224961 |
| 56 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.62414706 |
| 57 | Pertussis_Homo sapiens_hsa05133 | 0.62115617 |
| 58 | Lysine degradation_Homo sapiens_hsa00310 | 0.60658674 |
| 59 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.60145142 |
| 60 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.59692468 |
| 61 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.58222308 |
| 62 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.57522985 |
| 63 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.56096892 |
| 64 | Insulin resistance_Homo sapiens_hsa04931 | 0.54460898 |
| 65 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.54154685 |
| 66 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.53427736 |
| 67 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.51496702 |
| 68 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.50966476 |
| 69 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.50780780 |
| 70 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.50369522 |
| 71 | Phagosome_Homo sapiens_hsa04145 | 0.50224534 |
| 72 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.49628266 |
| 73 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.49596491 |
| 74 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.47663898 |
| 75 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.46859087 |
| 76 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.46471135 |
| 77 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.46315310 |
| 78 | Shigellosis_Homo sapiens_hsa05131 | 0.46246692 |
| 79 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.46196421 |
| 80 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.45899916 |
| 81 | Renin secretion_Homo sapiens_hsa04924 | 0.45636241 |
| 82 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.45410283 |
| 83 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.44536610 |
| 84 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.43363782 |
| 85 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.39928973 |
| 86 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.39889751 |
| 87 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.39213994 |
| 88 | Endometrial cancer_Homo sapiens_hsa05213 | 0.38693615 |
| 89 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.38265139 |
| 90 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.38163819 |
| 91 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.38057684 |
| 92 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.37743015 |
| 93 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.36828982 |
| 94 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.36609285 |
| 95 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.36435523 |
| 96 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.34214705 |
| 97 | ABC transporters_Homo sapiens_hsa02010 | 0.34146137 |
| 98 | HTLV-I infection_Homo sapiens_hsa05166 | 0.33819140 |
| 99 | Phototransduction_Homo sapiens_hsa04744 | 0.32525513 |
| 100 | Taste transduction_Homo sapiens_hsa04742 | 0.31324500 |

